ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BIOA vs FULC // 10Y YIELD & FRED MACRO BETA

BioAge Labs Inc. (NASDAQ) VS. Fulcrum Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: BIOA 0 — FULC 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BIOA VS. FULC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BIOA FULC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -20.97% — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 5.66 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 2/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.6 48.7 -5.10 FULC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $269.4M $283.4M -$14.0M FULC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BIOA REV FULC REV BIOA GROSS % FULC GROSS % BIOA FCF FULC FCF
FY 2025 $9.0M $237.4M — — -$82.3M -$60.4M
FY 2024 $218.9M $61.3M — — -$51.9M -$2.5M
FY 2023 $135.5M $309.9M — — -$37.4M -$91.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BIOA // BETA —
FULC // BETA —